Hair & Skin

Supporting Skin Renewal: One Patient’s Experience with Vitiligo

One patient’s experience: a 63-year-old woman with vitiligo whose earlier treatments had not improved her skin. After a six-month protocol, she noticed repigmentation in previously depigmented patches.

Individual outcomes vary. Results are not guaranteed.

Age
63 years old
Gender
Female
Ethnicity
White
  1. Medical History

    No allergies or genetic diseases. History of depression treated with SSRIs and SNRIs for 12 years. Moderate alcohol consumption (4-5 drinks per week), daily coffee intake (2-3 cups/day), and received multiple vaccines since childhood. Additionally, has been diagnosed with an autoimmune disorder and currently on Ruxolitinib.

  2. Presenting Complaint

    She presented with vitiligo; a skin condition characterized by depigmented patches due to the loss of melanocytes. Despite previous treatments for her autoimmune disorder, including immunosuppressives, she had not experienced significant improvement in her vitiligo.

  3. Treatment Approach

    Due to the limited success of conventional treatments, she opted for regenerative cell therapy to target her vitiligo. Over the course of six months, she received six treatment sessions, each consisting of six units of complete regenerative cell factors. The treatment was administered via intravenous infusion, subcutaneous injections, and topical application by micro-channel.

  4. Clinical Course

    Following the completion of the six-month treatment protocol, she experienced visible improvements in her vitiligo-affected skin. The regenerative cell therapy targeted the underlying factors contributing to depigmentation and aimed to stimulate melanocyte regeneration.

  5. Outcome

    The outcomes of the regenerative cell therapy were promising for her:

    Phenotypic Changes in Melanocytes: She noticed visible changes in the pigmentation of her epidermal melanocytes, with repigmentation occurring in previously depigmented patches.

    Collagen and Elastin Production: In addition to addressing vitiligo, the therapy also resulted in increased collagen and elastin production, leading to tightening of the skin at the neck and jaw lines.

  6. Follow-Up

    She continued to be monitored closely following the completion of the treatment protocol. Regular assessments of her vitiligo-affected skin were conducted to evaluate the long term efficacy of the regenerative cell therapy.

All Case Studies